Genentech Must Pay $300M In Royalties Case: Court

Law360, New York (April 24, 2008, 12:00 AM EDT) -- The California Supreme Court ruled Thursday that biotech company Genentech must pay $300 million in compensatory damages to City of Hope National Medical Center in a dispute over royalties on insulin and human growth hormone, but the court blocked $200 million in punitive damages.

The court's ruling reversed part of a 2004 state appellate court decision, which upheld the entire $500 million in damages awarded by a Los Angeles County Superior Court jury in 2002. At the time, it was the largest award ever upheld in...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.